Public-interest investigation desk
Documentation, accountability, and a quieter place to report what telehealth gets wrong.
We stand for patients and the public record — not clinics, pharmacies, processors, or affiliate programs. We collect complaints and packaging evidence, track industry patterns, and share curated material with regulators, newsrooms, and nonprofit watchdogs when the facts justify it.
Transparency here means honest product identity, a named pharmacy of record, marketing that matches the science, clear affiliate compensation, and payment rails that do not look the other way. Submissions are private by default. We are not a law firm, government agency, or medical provider.
Active
EllieMD LLC
ActiveSells peptides to everyday customers for human use as pharmacy medicine — while telling them the products are not research grade. A licensed compounding pharmacy cannot currently sell these as patient medicine.
Open investigation hub →
Tracked public cases
News investigations, agency actions, and litigation peers — each with a public-record summary the findings desk can open for pattern context.
Mochi / Aequita
KING 5 “$elling $kinny” series on telehealth weight-loss drugs and Aequita Pharmacy — state inspection, Immediate Jeopardy finding, and halt of GLP-1 compounding at the supplier.
Zappy / Ousia
NPR pharmaceuticals reporting: sterile compounding tied to a telehealth brand without the sterile authority patients assumed — followed by license relinquishment under scrutiny.
MEDVi
Business Insider on Meta ads using AI / fabricated “doctor” personas; FDA warning letter on compounder identity and GLP-1 brand-equivalence claims — company says the cited site was an affiliate.
Henry Meds
Named defendant in Eli Lilly’s 2025 false-advertising / compounded GLP-1 telehealth litigation cluster — part of brand-name manufacturer pushback against compounder marketing.
Fella
Men’s telehealth brand named in Eli Lilly’s 2025 compounded GLP-1 litigation cluster alongside other cash-pay compounder platforms.
Willow
Telehealth compounder named with peers in Eli Lilly’s 2025 false-advertising / compounded GLP-1 enforcement cluster.
Hims
National DTC telehealth scale-up; public reporting on HHS→DOJ referral path involving oral compounded semaglutide — an agency-escalation case study.
Sharing channels
Where we share documentation
When we document telehealth harms, we may file or share packages with regulators, state boards, payment networks, and nonprofit / certification channels. We list those institutions here so patients and journalists know who may receive the information we collect.
Listing is not an endorsement, sponsorship, or formal joint venture. These entities do not operate Telehealth Transparency. Sharing follows our methodology and counsel review; your contact details are not published by default.
Federal agencies
Drug, advertising, and consumer-protection channels for health and deception filings.
U.S. Food and Drug Administration (FDA)
Unlawful sales · Bad Ad · MedWatch · OCI (counsel-gated)
Federal Trade Commission (FTC)
ReportFraud · deceptive marketing · MLM patterns
FBI Internet Crime Complaint Center (IC3)
Significant internet fraud / consumer loss
State boards & agencies
Sovereign licensing and consumer-protection agencies — they can inspect facilities, discipline licensees, and open AG investigations. Not advocacy groups: each board’s power is tied to a specific state’s Pharmacy Practice Act or medical board statute.
State boards of pharmacy
Facility and pharmacist-in-charge complaints · compounding / non-resident shippers · board finder via NABP
State medical boards
Prescriber licensing · telehealth standard-of-care
State attorneys general
Consumer fraud · MLM · AG finder via NAAG
Payment networks & processors
Card networks, wallets, and checkout processors that can restrict merchant boarding when high-risk healthcare compliance gaps are documented. Commercial — not government boards.
Visa
Card network merchant practices / incident reporting
Mastercard
Card network shopping / merchant compliance channels
American Express
Merchant Services · online Rx sales policy
PayPal
Acceptable Use · online pharmacy / telehealth checkout (including wallet rails when present)
Acquiring / sponsor banks
Case-specific settlement banks when checkout documentation supports it (counsel-gated)
Nonprofit, certification & consumer-integrity bodies
Advocacy, ad monitoring, certification lookups, and consumer-marketplace channels. They tip, petition, certify, or publish — they do not revoke a pharmacy license (that’s still a state board). NABP sits here as the boards’ association tip desk, not as a substitute for a state board filing.
Truth in Advertising (TINA.org)
Ad alerts · tips@ · health / MLM marketing claims
National Consumers League (NCL)
Fraud.org · telehealth / GLP-1 consumer-protection coalitions
Alliance for Safe Online Pharmacies (ASOP Global)
Online pharmacy / telehealth safety · buysaferx.pharmacy
Partnership for Safe Medicines
Counterfeit / unsafe medicines · supply-chain education
National Association of Boards of Pharmacy (NABP)
Report a suspicious online pharmacy site · .pharmacy / Verified Internet Pharmacy Practice Sites — routes intel to boards; not itself a state licensee board
Better Business Bureau (BBB)
Business practice complaints · public complaint record (marketplace, not licensing)
LegitScript
Online pharmacy / telehealth merchant certification monitoring · public listing lookup (documentation source, not a board complaint desk)
Aimed Alliance
Patient-access / health policy coalition
Public Citizen Health Research Group
FDA / drug-safety policy watchdog · less company-specific intake
Direct Selling Self-Regulatory Council (DSSRC)
MLM earning / health claim inquiries (industry self-reg, not a government board)
Full sharing rules → Methodology